AMAG Overview
Upcoming Projects (AMAG)
-
Don’t see a project related to the company you care about? Create your own!
Executed Projects (AMAG)
-
Don’t see a project related to the company you care about? Create your own!
Expired Projects (AMAG)
-
An expert’s view on Vyleesi (Bremelanotide) in Female sexual dysfunction after the FDA's approval
Tickers: PTN, AMAG
Execute By: Jul 05, 2019
Upcoming & Overdue Catalysts (AMAG)
-
Don’t see a catalyst related to the company you care about? Create your own!
Occurred Catalysts (AMAG)
-
AMAG's (AMAG) Makena in Preterm birth Advisory Committee planned for October 29, 2019
Ticker: AMAG
Occurred on: Oct 29, 2019 -
AMAG Pharmaceuticals' (AMAG) Makena approved as treatment to reduce preterm birth
Ticker: AMAG
Occurred on: Feb 14, 2018 -
Feraheme for treating Adults with Iron Deficiency Anemia (IDA) sNDA expected in late 2017
Ticker: AMAG
Occurred on: Aug 31, 2017 -
AMAG Pharmaceuticals (AMAG) preparing for sNDA submission on Makena, a treatment to reduce preterm birth, in the second quarter of 2017
Ticker: AMAG
Occurred on: Apr 17, 2017 -
AMAG Pharmaceuticals Announces FDA Approval of New Single-Dose, Preservative-Free Makena (hydroxyprogesterone caproate injection)
Ticker: AMAG
Occurred on: Feb 23, 2016
Strategic Initiatives (AMAG)
-
Covis Group to Acquire AMAG Pharmaceuticals (AMAG) in $647 Million Deal
Ticker: AMAG
Announcement Date: Oct 01, 2020
